Bill > HR5461

This bill extends funding for the Special Diabetes Programs for Type I diabetes by amending the Public Health Service Act to provide $160 million annually for fiscal years 2026 through 2030. Specifically, the bill modifies Section 330B(b)(2), which governs diabetes research and support programs, to add a new funding provision that allocates $160 million per year for five consecutive years, with those funds remaining available for use even after the initial fiscal year. The bill is titled the "Special Diabetes Program Reauthorization Act of 2025" and represents a continuation of existing federal support for research, prevention, and treatment of Type I diabetes, ensuring consistent funding for critical medical research and support programs over the next five years.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/5461/all-info